Search

everythinglearnresearchcommunity

for

Search:↓

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Antibiotics often cause skin reactions, making them a major health concern.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Effective symptom management in IBD improves quality of life and prevents complications.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

A dog with a pituitary tumor developed tertiary hypothyroidism, improved with treatment, but was later euthanized due to neurological issues.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.